Article info
PDFTherapeutics/Prevention
Systematic review with meta analysis
Treatment for chronic Strongyloides stercoralis infection: moderate-to-low evidence shows that ivermectin is more effective and tolerable than albendazole and thiabendazole, respectively
- Correspondence to : Dr Federico Gobbi, Centre for Tropical Diseases, Ospedale Sacro Cuore Don Calabria, Via Sempreboni 5, Negrar 37024, Italy; federico.gobbi{at}sacrocuore.it
Citation
Treatment for chronic Strongyloides stercoralis infection: moderate-to-low evidence shows that ivermectin is more effective and tolerable than albendazole and thiabendazole, respectively
Publication history
- First published April 25, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/